Cover Image

Not for Sale



View/Hide Left Panel

Index

A

Acceptance scores, 7483

Acquired Immune Deficiency Syndrome (AIDS) agent, 154155

Additive model, 8082

Adenovirus, 155156

Adverse reactions

estimation of, 94, 96, 100

Herpesvirus varicellae vaccine, 333

influenza virus vaccines, 356

pertussis vaccine, 172173, 175, 177

prediction criteria, 65

respiratory syncytial virus vaccine, 404

streptococcus group B vaccine, 429

Age-neutral sensitivity analysis hypothetical case, 135

Anaerobic bacteria, 156157

Annual costs, 104109

Annualized net expected costs, 31, 33

Annualized net expected health benefits, 31

Annualized present value of expected cost reductions, 115116

Annualized present value of expected health benefits, 9495, 110

Annualized present value of expected net costs, 120

Annualized present value of expected reduction in morbidity costs, 95

Anticipated vaccine utilization

calculation of, 8386

coccidioidomycosis, 193

cytomegalovirus, 226227

Hemophilus influenzae, 244245

hepatitis A virus, 257258

hepatitis B virus, 271272

herpes simplex viruses, 300301

Herpesvirus varicellae, 333334

influenza viruses, 357358

Neisseria gonorrhoeae, 377378

parainfluenza viruses, 393

pertussis, 179

respiratory syncytial virus, 405

rotavirus, 420

sensitivity analysis, 138, 140143

streptococcus group B, 433434

Annualized values, 30

Availability of vaccine, 68

B

Bacteroides fragilis, 156

Basic research priorities, 154

Benefit-cost analysis, 24

Bordetella pertussis, 171181

C

Candidate selection, 36, 5963, 153, 154

Central analysis, 128135

Chlamydia, 157

Clostridium botulinum, 156

Clostridium difficile, 156

Clostridium perfringens, 156

Clostridium tetani, 157

Coccidioides immitis. See Coccidioidomycosis

Coccidioidomycosis, 183195

Control suitability

coccidioidomycosis, 189

cytomegalovirus, 218219

Hemophilus influenzae type B, 240

hepatitis A virus, 256

hepatitis B virus, 267268

herpes simplex viruses, 292

Herpesvirus varicellae, 326327

influenza viruses, 352

Neisseria gonorrhoeae, 372, 374

parainfluenza viruses, 389

pertussis, 174

respiratory syncytial virus, 401

rotavirus, 416

streptococcus group B, 429, 431

Cost of illness

coccidioidomycosis, 193195

cytomegalovirus, 227232



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 453

OCR for page 453

OCR for page 453

OCR for page 453

OCR for page 453

OCR for page 453